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Brainstem extracts from 6-month-old homozygous p301s 
tau transgenic mice (prepared and analysed as previously 
described [3]) were injected into the peritoneal cavity of 
3-month-old heterozygous mice, an age at which they lack 
tau deposits. The mice were analysed 9 months after the 
final injection.
The number of Gallyas silver-positive cells was assessed 
using a scanning light microscope. Maps of entire brain 
sections, along with the annotation of the brain outline 
and artificially altered areas, were used for the counting 
of black Gallyas-positive and blue haematoxylin-positive 
structures (supplementary Fig. 4). Gallyas per cell nucleus 
(G/N) ratios were counted, thus reflecting the number 
of silver-positive cells. G/N ratios were calculated per 
field of view (20× objective, 661.5 × 372.1 μm). Gauss-
blurred ratiometric images (sigma = 70 pixels, pixel edge 
length = 3.45 μm) were superimposed for the control and 
experimental groups. subsequently, a pixel-wise student’s 
t test was performed and the probability (p) values were 
plotted, with the statistically significant portion (p < 0.05) 
being represented as a colour map (Fig. 2). Our ratiometric 
approach (G/N) only compares equivalent brain regions to 
each other. Thus, despite anatomical differences in densi-
ties of nuclei, our comparative maps remain unbiased.
Although groups of mice injected intraperitoneally (Ip) 
with brainstem homogenate from either p301s tau trans-
genic mice (with tau filaments) or control (CO) mice (with-
out tau filaments) formed Gallyas-positive structures in 
the brain, there were also significant differences between 
the two groups (Fig. 1). G/N ratios (Fig. 2a, left panel) 
showed a marked increase in the number of silver-posi-
tive structures in the brainstem and neocortex of mice Ip 
injected with p301s brainstem extract. The probability map 
(Fig. 2a, right panel) showed large differences in secondary 
motor cortex, ventral orbital cortex and olfactory nucleus. 
soluble tau forms insoluble aggregates following the 
intracerebral injection of tau inclusions [3, 4]. This is 
reminiscent of prions, the intracerebral injection of which 
induces aggregation of cellular prion protein (prpC) [9]. 
Multiple routes of administration can transmit prion 
diseases, with the intracerebral route being more effec-
tive than the intraperitoneal route, which is in turn more 
effective than the oral route [7]. The oral administration of 
aggregated apolipoprotein A-II [11] and aggregated amy-
loid protein A (AA) [8] has also been shown to promote 
systemic amyloidosis. Moreover, intraperitoneally injected 
aggregated Aβ-containing extracts increased cerebral 
β-amyloidosis [5]. Here, we report for the first time that the 
intraperitoneal injection of tau seeds can also induce intra- 
cerebral tauopathy.
We used homozygous and heterozygous mice transgenic 
for human mutant p301s tau [2]. In heterozygous mice, 
tau aggregation forms later than in homozygous mice, 
and heterozygous mice live longer than their homozy-
gous counterparts (15 months as opposed to 6 months). 
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More ventral regions, including pallidum and lateral preop-
tic area, showed more silver-positive inclusions in p301s 
brainstem-injected mice, as did lateral habenular nucleus, 
thalamic nucleus, pretectal nucleus and mesencephalic 
reticular formation. In the brainstem, pontine reticular 
nucleus, gigantocellular reticular nucleus, median vestibu-
lar nucleus and solitary tract showed the largest increase 
in Gallyas-positive inclusions (supplementary Fig. 2). The 
hippocampus remained unaffected. At the age of analysis 
(12 months), brains of heterozygous p301s mice develop 
neuronal inclusions made of hyperphosphorylated (AT8 
positive, pretangles) and aggregated tau (AT100- and 
Gallyas silver-positive, classical tangles). Both AT8 and 
AT100 tau immunoreactivity (supplementary Fig. 3) as 
well as silver staining in Ip-injected mice were increased 
compared to non-injected mice, but the pattern (brain dis-
tribution and morphology) of tau pathology remained 
unchanged. Age-matched wild-type mice injected intra-
peritoneally with p301s brainstem extract failed to develop 
cerebral tauopathy.
We previously showed that the intracerebral injection of 
silver-positive brainstem extract from mice homozygous for 
human mutant p301s tau into mice transgenic for human 
wild-type tau (line ALZ17) induced the formation of silver-
positive inclusions [3]. To investigate if this is also true of 
another mouse model of tauopathy, we injected brainstem 
extract from homozygous mice transgenic for human 
mutant p301s tau into the hippocampus and overlying 
cerebral cortex of 3-month-old heterozygous mice and com-
pared the relative efficiency of intracerebral and intraperi-
toneal injections after 9 months. Following intracerebral 
injection, numerous Gallyas-positive structures were present 
in the CA1 region of the hippocampus and in the secondary 
motor cortex (supplementary Fig. 1A). No silver-positive 
structures were present in these regions following the intra-
peritoneal injection of control extracts. Heat maps revealed 
a significant increase in the G/N ratio in the hippocam-
pus following the intracerebral injection of p301s brain-
stem extract into heterozygous transgenic p301s tau mice 
(Fig. 2b, left panel). The p maps showed statistically signif-
icant differences between groups in the hippocampal area, 
which was a site of intracerebral injection (Fig. 2b, right 
panel; supplementary Fig. 1B). Moreover, the G/N ratio 
was increased more in brainstem and neocortex following 
intracerebral than after intraperitoneal injections. Heart, 
lungs, liver, spleen and kidneys from injected heterozygous 
p301s tau mice were all silver-negative and tau-negative. 
No sign of inflammation was detected in either the brain or 
the periphery.
These findings demonstrate that aggregated tau seeds, 
such as prions and Aβ aggregates, can reach the cen-
tral nervous system from the periphery. The underlying 
mechanisms remain to be determined. The replication 
of peripherally applied prions and their translocation to 
the brain are dependent on haematopoietic and stromal 
immune cells, together with the sympathetic innervation 
of abdominal lymphoid organs [1]. In mouse models of 
AA-amyloidosis, peripheral blood monocytes transported 
the aggregates [10]. It therefore appears that amyloid 
seeds can be carried by blood cells. This may also be 
true of aggregated tau. seeding may require the presence 
of unfolded monomers [6]. It remains to be determined 
if tau seeds are able to replicate in the peripheral nerv-
ous system. Their transport to the brain may not require 
endogenous tau, which is not expressed by lymphoreticu-
lar cells. This is unlike prion propagation, which depends 
on the expression of prpC by stromal and haematopoietic 
cells. Because the central nervous system is affected in 
clinical tauopathy, the intracerebral route of seed delivery 
could be expected to be more effective than the intraperi-
toneal route. This was the case here, where more silver-
positive structures formed in brainstem, hippocampus and 
neocortex following the intracerebral injection of 5 μl 
brainstem homogenate (0.19 μg of τ/μl of homogenate) 
than after the intraperitoneal injection of 200 μl homoge-
nate (0.19 μg of τ/μl of homogenate). It follows that, 
like prion diseases, tauopathies can be seeded in the brain 
by tau aggregates delivered peripherally, although the 
intraperitoneal administration was less effective than the 
Fig. 1  Intraperitoneal injection of aggregated tau-rich homogen-
ate increases the number of silver-positive tau inclusions in brain. 
Gallyas-Braak staining of the brainstem of 12-month-old mice hete-
rozygous for transgenic human mutant p301s tau showed an increase 
in the number of silver-positive structures following the intraperito-
neal injection of brainstem extract from 6-month-old homozygous 
mice, when compared with non-injected controls. The mice were 
injected at the age of 3 months. silver staining was negative in the 
neocortex of non-injected animals, with some silver-positive struc-
tures in the neocortex of intraperitoneally injected mice. The brain 
sections were counterstained with haematoxylin–eosin. Scale bar 
100 μm
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intracerebral route. These findings underscore the urgent 
need for additional work on the aetiology and pathogen-
esis of tauopathies.
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Fig. 2  Gallyas silver-positive structures per cell nucleus (G/N ratios) 
in non-injected controls (CO) and in mice injected with aggregated 
tau-rich homogenate either intraperitoneally (Ip) or intracerebrally 
(IC). a Left panel colour map representing average G/N ratios (CO 
and Ip) of five sagittal brain sections per group. Right panel statis-
tically significant differences were determined by pixel-based t tests 
and colour coded in the range of <0.05. Ip-injected mice had higher 
G/N ratios in the brainstem and neocortex than CO mice. M2 second-
ary motor cortex, VO ventral orbital cortex, Olf olfactory nucleus, 
Pall pallidum, PreOp lateral preoptic area, Hab lateral habenular 
nucleus, Thal thalamic nucleus, PreTec pretectal nucleus, MesRet 
mesencephalic reticular formation, Pont pontine reticular nucleus, 
Gig gigantocellular nucleus, Vest median vestibular nucleus, Sol 
solitary tract. Dagger symbol an enlarged version is given in supple-
mentary Fig. 2. each group consisted of five mice. Asterisk round-
ing leads to an absolute zero, which reflects an infinitely small value 
(p is not identical to 0). b Left panel colour map representing aver-
age G/N ratios of five sagittal brain sections from IC-injected mice. 
Right panel statistically significant differences between the three 
groups were determined by pixel-based t tests and colour coded in 
the range of <0.05. statistically significant differences were appar-
ent between non-injected and injected animals, with the major differ-
ences between Ip- and IC-injected animals being located in the hip-
pocampus, one of the two intracerebral injection sites. each group 
consisted of five mice. Asterisk rounding leads to an absolute zero, 
which reflects an infinitely small value (p is not identical to 0)
